Project Peregrine — Independent Sponsor Healthcare Services Acquisition, Summer 2026 Close

Project Peregrine — IS Sponsor Healthcare Services Acquisition, Summer 2026 Close Operator-led independent sponsor raising junior capital and equity for a healthcare services platform acquisition. Looking to connect with family offices, accredited investors, mezzanine providers, and structured capital partners interested in defensive B2B services exposure. Deal Snapshot — Target: 30+ year B2B clinical services business in the IDD (intellectual and developmental disabilities) nurse delegation space — Size: ~$20M acquisition / 6.54x adjusted EBITDA — Financials: $3M adjusted EBITDA on $9.6M revenue, 30%+ EBITDA margin — Position: ~40% segment market share in primary state market — Revenue model: B2B fixed per-person monthly fee revenue, zero direct Medicare or Medicaid billing exposure — Customer base: 75+ customer agencies, 11+ year average tenure on top 10 customers — Margin protection: Contractual cost-adjustment escalators tied to state reimbursement trends — Seller commitment: $3M rollover at first-loss subordination ahead of all outside capital — Diligence status: Buy-side QoE substantially complete via Xylinx Capital Structure — Senior debt advisory in motion with established LMM lender — Junior capital and equity layers open to structured capital partners (subordinated debt, mezzanine, preferred equity, common equity, blended positions all in scope) — Indicative target leverage###-###-#### 5x EBITDA — Total sources ~$21.4M Platform Thesis The lead acquisition is the first asset in EHH's healthcare services platform. Post-close build-out includes anchored geographic expansion (existing customer partner relationship in adjacent state), service line adjacency (assisted living and skilled nursing facility delegation), clinical operating leverage, and tuck-in acquisitions###-###-#### targets identified). Platform growth is upside optionality. Why This Deal — Regulatorily mandated demand (state DDA framework requires nurse delegation services for licensed agencies) — Recession-resistant B2B service in defensive healthcare sub-sector — Defensible market position via 30+ year operating history, segment scale, and customer tenure — No direct reimbursement billing exposure (zero Medicare/Medicaid billing risk) — Contractual revenue escalators provide structural margin protection Team & Advisors EHH leadership: 240+ years combined healthcare operating experience, 50+ prior acquisitions. Coker Group as integration partner; Holland & Knight as transaction counsel. Engagement Accredited investors only. Materials available post-NDA. Direct message for an introductory conversation or to request the full information memorandum. Jonathan Numa, Founder, Elite Health Holdings ###-###-#### redacted